1210858

Apellis Pharmaceuticals, Inc. — FEI 3016603289

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 14, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Waltham, MA (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)